Chronic kidney disease is associated with oxidative stress independent of hypertension

Clinical Nephrology

Volumn 61, Issue 6, 2004, Pages 377-383

  Agarwal, R ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Ambulatory blood pressure monitoring; Carbonyl stress; Chronic kidney disease; Hypertension; Malondialdehyde; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CREATININE; GLUTATHIONE; LIPID; MALONALDEHYDE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MONITORING; CARBONYLATION; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; FEMALE; HEMODYNAMICS; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROTEIN MODIFICATION; STATISTICAL ANALYSIS; URINE LEVEL;

EID: 2942702379     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP61377     Document Type: Article

References (40)

1. Agarwal R, Chase SD 2002 Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 775: 121-126
2. Agarwal R 2003 Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Am J Physiol Renal Physiol 284: F863-F869
3. Annuk M, Zilmer M, Lind L, Linde T, Fellstrom B 2001 Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 12: 2747-2752
4. Anonymous 2000 Statistica User Manual (5.5) 2000 Tulsa, OK, USA. StatSoft, Inc. 2000. Ref Type: Computer Program
5. Attia DM, Verhagen AM, Stroes ES, van Faassen EE, Grone HJ, De Kimpe SJ, Koomans HA, Braam B, Joles JA 2001 Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. J Am Soc Nephrol 12: 2585-2593
6. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, Dominiczak AF 2000 Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 101: 2206-2212
7. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF 2001 Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens 10: 247-255
8. Boaz M, Matas Z, Biro A, Katzir Z, Green M, Fainaru M, Smetana S 1999 Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int 56: 1078-1083
9. Cai H, Harrison DG 2000 Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844
10. Cheng ZJ, Vaskonen T, Tikkanen I, Nurminen K, Ruskoaho H, Vapaatalo H, Muller D, Park JK, Luft FC, Mervaala EM 2001 Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension 37: 433-439
11. Daschner M, Lenhartz H, Botticher D, Schaefer F, Wollschlager M, Mehls O, Leichsenring M 1996 Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int 50: 1268-1272
12. Esterbauer H, Cheeseman KH 1990 Determination of aldehydic lipid peroxidation products: malondialdehyde and 4-hydroxynonenal. Methods Enzymol 186: 407-421
13. Handelman GJ, Walter MF, Adhikarla R, Gross J, Dallal GE, Levin NW, Blumberg JB 2001 Elevated plasma F2 isoprostanes in patients on long-term hemodialysis. Kidney Int 59: 1960-1966
14. Hasdan G, Benchetrit S, Rashid G, Green J, Bernheim J, Rathaus M 2002 Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int 61: 586-590
15. Haugen EN, Nath KA 1999 The involvement of oxidative stress in the progression of renal injury. Blood Purif 17: 58-65
16. Haugen EN, Croatt AJ, Nath KA 2000 Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 58: 144-152
17. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, 0shima T, Chayama K 2002 Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346: 1954-1962
18. Himmelfarb J, McMonagle E, McMenamin E 2000 Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 58: 2571-2578
19. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM 2002 The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524-1538
20. Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, Tatge H, Drexler H 2001 Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 103: 799-805
21. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ 1987 New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 79: 1379-1387
22. Lacy F, O'Connor DT, Schmid-Schonbein GW 1998 Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 16: 291-303
23. Lim PS, Wang NP, Lu TC, Wang TH, Hsu WM, Chan EC, Hung WR, Yang CC, Kuo IF, Wei YH 2001 Evidence for alterations in circulating low-molecular weight antioxidants and increased lipid peroxidation in smokers on hemodialysis. Nephron 88: 127-133
24. Lip GY, Edmunds E, Nuttall SL, Landray MJ, Blann AD, Beevers DG 2002 Oxidative stress in malignant and nonmalignant phase hypertension. J Hum Hypertens 16: 333-336
25. Malle E, Woenckhaus C, Waeg G, Esterbauer H, Grone EF, Grone HJ 1997 Immunological evidence for hypochlorite-modified proteins in human kidney. Am J Pathol 150: 603-615
26. Miyata T, Sugiyama S, Saito A, Kurokawa K 2001 Reactive carbonyl compounds related uremic toxicity ("carbonyl stress" . Kidney Int Suppl 78: S25-S31
27. Nath KA, Grande J, Croatt A, Haugen J, Kim Y, Rosenberg ME 1998 Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression. Kidney Int 53: 367-381
28. Nguyen-Khoa T, Massy ZA, De Bandt JP, Kebede M, Salama L, Lambrey a Witko-Sarsat V, Drueke TB, Lacour B, Thevenin M2001 Oxidative stress and hemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 16: 335-340
29. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS 2002 Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB. Kidney Int 61: 186-194
30. Park JB, Touyz RM, Chen X, Schiffrin EL 2002 Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15: 78-84
31. Polidori MC, Stahl W, Eichler O, Niestroj I, Sies H 2001 Profiles of antioxidants in human plasma. Free Radic Biol Med 30: 456-462
32. Quinones-Galvan A, Pucciarelli A, Fratta-Pasini A, Garbin U, Franzoni F, Galetta F, Natali A, Cominacini L, Ferrannini E 2001 Effective blood pressure treatment improves LDL cholesterol susceptibility to oxidation in patients with essential hypertension. J Intern Med 250: 322-326
33. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG 1996 Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923
34. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ 2001a Role of immunocompetent cells in non-immune renal diseases. Kidney Int 59: 1626-1640
35. Rodriguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, Johnson RJ 2001b Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int 59: 2222-2232
36. Rodriguez-Iturhe B, Quiroz Y, Nava M, Bonet L, Chavez M, Herrera-Acosta J, Johnson RJ, Pons HA 2002 Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282: F191-F201
37. Schnackenberg CG 2002 Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282: R335-R342
38. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A 2001 Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38: 274-279
39. Vaziri ND, Oveisi F, Ding Y 1998 Role of increased oxygen-free radical activity in the pathogenesis of uremic hypertension. Kidney Int 53: 1748-1754
40. Wassmann S, Laufs U, Baumer AT, Muller K, Ahlbory K, Linz W, Itter G, Rosen R, Bohm M, Nickenig G 2001 HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 37: 1450-1457